The efficacy and safety of Kytril® tablets (2MG) once daily in patients receiving at least 10 fractions of upper abdominal radiation for malignancy
R. Lanciano, D.M. Sherman, J. Michalski, A. Preston, K. Yocom, C. FriedmanVolume:
42
Year:
1998
Language:
english
DOI:
10.1016/s0360-3016(98)80260-5
File:
PDF, 91 KB
english, 1998